Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2000
Single User License Price INR 134900
Corporate User License Price USD 6000
Corporate User License Price INR 404700
Site License Price USD 4000
Site License Price INR 269800
Request a Quote

Report Title

Yellow Fever-Pipeline Review, H1 2017

Quote Request for License Type
License Type Price  
Single User License USD 2000
Site License USD 4000
Enterprise Wide License USD 6000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Yellow Fever-Pipeline Review, H1 2017


Quote Request for License Type
License Type Price  
Single User License USD 2000
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Yellow Fever-Pipeline Review, H1 2017

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Yellow Fever-Pipeline Review, H1 2017



Executive Summary

Yellow Fever-Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever-Pipeline Review, H1 2017, provides an overview of the Yellow Fever (Infectious Disease) pipeline landscape.

Yellow fever is an acute systemic illness (hemorrhagic fever) caused by the Flavivirus. It is spread by mosquitoes. Symptoms include irregular heartbeats, bleeding, vomiting, coma, delirium, fever, headache and muscle aches. There is no specific treatment for yellow fever but can be treated to relieve the symptoms.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Yellow Fever-Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Yellow Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 2, 8 and 4 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 2 and 1 molecules, respectively.

Yellow Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Yellow Fever (Infectious Disease).

The pipeline guide reviews pipeline therapeutics for Yellow Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Yellow Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Yellow Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Yellow Fever (Infectious Disease)

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Yellow Fever (Infectious Disease).

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Yellow Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Yellow Fever-Overview

Yellow Fever-Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Yellow Fever-Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Yellow Fever-Companies Involved in Therapeutics Development

Arno Therapeutics Inc

Bavarian Nordic A/S

BioCryst Pharmaceuticals Inc

Ennaid Therapeutics LLC

Fab'entech SA

iBio Inc

Johnson & Johnson

NewLink Genetics Corp

Sihuan Pharmaceutical Holdings Group Ltd

Valneva SE

Yellow Fever-Drug Profiles

(arenavirus + yellow fever) vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AR-12-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

FDX-000-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

galidesivir-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

JK-05-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit NS4B for Dengue and Yellow Fever Virus Infections-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Viral Infections-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit NS5 for Japanese Encephalitis and Viral Infections-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Synthetic Peptides for Yellow Fever-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

XRX-001-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever [strain YF17D] vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

yellow fever vaccine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Yellow Fever-Dormant Projects

Yellow Fever-Product Development Milestones

Featured News & Press Releases

Jul 27, 2016: Bavarian Nordic Announces Initiation of NIH Sponsored Phase 1 Trial of MVA-BN-based Yellow Fever Vaccine

Jul 27, 2016: NIH launches early-stage yellow fever vaccine trial

Apr 07, 2011: Xcellerex Announces Positive Results From Phase I Clinical Trial Of XRX-001

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Number of Products under Development for Yellow Fever, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Universities/Institutes, H1 2017

Number of Products by Targets, H1 2017

Number of Products by Stage and Targets, H1 2017

Number of Products by Mechanism of Actions, H1 2017

Number of Products by Stage and Mechanism of Actions, H1 2017

Number of Products by Routes of Administration, H1 2017

Number of Products by Stage and Routes of Administration, H1 2017

Number of Products by Molecule Types, H1 2017

Number of Products by Stage and Molecule Types, H1 2017

List of Tables

Number of Products under Development for Yellow Fever, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Universities/Institutes, H1 2017

Products under Development by Companies, H1 2017

Products under Development by Universities/Institutes, H1 2017

Number of Products by Stage and Target, H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017

Number of Products by Stage and Route of Administration, H1 2017

Number of Products by Stage and Molecule Type, H1 2017

Yellow Fever-Pipeline by Arno Therapeutics Inc, H1 2017

Yellow Fever-Pipeline by Bavarian Nordic A/S, H1 2017

Yellow Fever-Pipeline by BioCryst Pharmaceuticals Inc, H1 2017

Yellow Fever-Pipeline by Ennaid Therapeutics LLC, H1 2017

Yellow Fever-Pipeline by Fab'entech SA, H1 2017

Yellow Fever-Pipeline by iBio Inc, H1 2017

Yellow Fever-Pipeline by Johnson & Johnson, H1 2017

Yellow Fever-Pipeline by NewLink Genetics Corp, H1 2017

Yellow Fever-Pipeline by Sihuan Pharmaceutical Holdings Group Ltd, H1 2017

Yellow Fever-Pipeline by Valneva SE, H1 2017

Yellow Fever-Dormant Projects, H1 2017

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Arno Therapeutics Inc, Bavarian Nordic A/S, BioCryst Pharmaceuticals Inc, Ennaid Therapeutics LLC, Fab'entech SA, iBio Inc, Johnson & Johnson, NewLink Genetics Corp, Sihuan Pharmaceutical Holdings Group Ltd, Valneva SE

Yellow Fever Therapeutic Products under Development, Key Players in Yellow Fever Therapeutics, Yellow Fever Pipeline Overview, Yellow Fever Pipeline, Yellow Fever Pipeline Assessment


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand